Clinical Trials
- Men's Health, Women's Health
Evaluating the Safety, Tolerability, Pharmacokinetics and Receptor Occupancy of BMS-984923
- Ages50 years - 80 years
- GenderBoth
- Mental Health & Behavioral Research
Imaging mGluR5 and synaptic density in psychiatric disorders
- Ages18 years - 80 years
- GenderBoth
- Mental Health & Behavioral Research
Imaging SV2A in mood disorders
- Ages18 years - 70 years
- GenderBoth
- Brain, Spinal Cord & Nervous System, Alzheimer's
Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
- Ages50 years - 90 years
- GenderBoth
- Brain, Spinal Cord & Nervous System, Alzheimer's
Study of BHV-4157 in Alzheimer's Disease (T2 Protect AD)
- Ages50 years - 85 years
- GenderBoth
- Alzheimer's
test
- Ages55 years - 80 years
- GenderBoth
- Alzheimer's
test
- Ages60 years - 85 years
- GenderBoth
- Alzheimer's
test
- Ages55 years - 80 years
- GenderBoth
- Aging, Mental Health & Behavioral Research
test
- Ages50 years - 85 years
- GenderBoth